首页 › 基金 › Octagon Capital Advisors LP › DBVT
Octagon Capital Advisors LP 对 DBVT 的持仓历史
DBV TECHNOLOGIES S A · 医疗保健
Octagon Capital Advisors LP 在 Q3 2026 的 13F 申报中披露持有 DBVT(DBV TECHNOLOGIES S A)574,200 股,市值约 US$6.8M,约占其申报组合的 0.90%,在其申报持仓中市值排名第 20 位。 Octagon Capital Advisors LP 最近 6 个申报季度中有 6 个季度披露了 DBVT 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Octagon Capital Advisors LP 对 DBVT 的持仓演变
Octagon Capital Advisors LP 于 Q2 2025 首次披露 DBVT 持仓:1,018,021 股(约 US$9.3M)。 该持仓在 Q1 2026 达到峰值 574,200 股,市值约 US$12.0M。 在 6 次申报中,Octagon Capital Advisors LP 0 次增持、1 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 574,200 股、市值约 US$6.8M。 持仓曾出现大幅变动:Q4 2025 减持约 44% (随后一个季度股价上涨 9%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 1.02M | $9.31M | 新进 |
| Q3 2025 | 1.02M | $10.18M | 持有 |
| Q4 2025 | 574.20K | $11.01M | 减持 |
| Q1 2026 | 574.20K | $12.00M | 持有 |
| Q2 2026 | 574.20K | $9.42M | 持有 |
| Q3 2026 | 574.20K | $6.75M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DBVT 与 13F 数据
DBVT(DBV TECHNOLOGIES S A)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 DBVT,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$43.0M), MPM BioImpact LLC (US$35.8M), Siren, L.L.C. (US$27.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DBVT 的基金
- RA CAPITAL MANAGEMENT, L.P. 3.66M 股 · $43.01M · Q3 2026
- MPM BioImpact LLC 3.04M 股 · $35.81M · Q3 2026
- Siren, L.L.C. 2.36M 股 · $27.71M · Q3 2026
- ADAR1 Capital Management, LLC 2.01M 股 · $23.65M · Q3 2026
- Vivo Capital, LLC 1.84M 股 · $21.69M · Q3 2026
- BAKER BROS. ADVISORS LP 1.46M 股 · $17.19M · Q3 2026
- Patient Square Capital LP 1.11M 股 · $13.00M · Q3 2026
- Redmile Group, LLC 373.42K 股 · $4.39M · Q3 2026
- Ishara Investments LP 270.00K 股 · $3.18M · Q3 2026
- Elmind Capital, LP 265.00K 股 · $3.12M · Q3 2026
- GREAT POINT PARTNERS LLC 250.00K 股 · $2.94M · Q3 2026
- Yiheng Capital Management, L.P. 170.14K 股 · $2.00M · Q3 2026
更多关于 Octagon Capital Advisors LP
常见问题
How long has Octagon Capital Advisors LP held DBVT?
Octagon Capital Advisors LP has disclosed DBVT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Octagon Capital Advisors LP's current position in DBVT?
As of Q3 2026, Octagon Capital Advisors LP holds 574.20K shares of DBVT (DBV TECHNOLOGIES S A), valued at $6.75M, representing 0.90% of its reported portfolio and ranking #20.
Has Octagon Capital Advisors LP been buying or selling DBVT?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP held unchanged its position in DBVT. The position peaked in Q1 2026 at 574.20K shares.
Which other funds hold DBVT?
Other major institutional holders of DBVT include RA CAPITAL MANAGEMENT, L.P., MPM BioImpact LLC, Siren, L.L.C., among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.